The HIV-derived protein Vpr52-96 has anti-glioma activity in vitro and in vivo.
Kübler J, Kirschner S, Hartmann L, Welzel G, Engelhardt M, Herskind C, Veldwijk MR, Schultz C, Felix M, Glatting G, Maier P, Wenz F, Brockmann MA, Giordano FA.
Kübler J, et al. Among authors: engelhardt m.
Oncotarget. 2016 Jul 19;7(29):45500-45512. doi: 10.18632/oncotarget.9787.
Oncotarget. 2016.
PMID: 27275537
Free PMC article.